Targeted Temperature Management after Intracerebral Hemorrhage (TTM-ICH): Methodology of a Prospective Randomized Clinical Trial

Abstract

Rationale

Intracerebral hemorrhage causes 15% of strokes annually in the United States, and there is currently no effective therapy.

Aims and hypothesis

This is a clinical trial designed to study the safety, feasibility, and efficacy of a protocol of targeted temperature management to moderate hypothermia in intracerebral hemorrhage patients.

Methods

The targeted temperature management after intracerebral hemorrhage trial is a prospective, single-center, interventional, randomized, parallel, two-arm (1:1) phase-II clinical trial with blinded end-point ascertainment. Intracerebral hemorrhage patients will be randomized within 18 h of symptom onset to either 72 h of targeted temperature management to moderate hypothermia (32–34°C) followed by a controlled rewarming at of 0·05–0·1°C per hour or 72 h of targeted temperature management to normothermia (36–37°C) using endovascular or surface cooling.

Outcomes

The primary outcome is the development of serious adverse events possibly and probably related to treatment. Secondary outcomes include in-hospital neurological deterioration between day 0–7, in-hospital mortality, functional outcome measured by the modified Rankin scale at discharge and 90 days, and effect of treatment allocation on cerebral edema and hematoma volume.

Discussion

Intracerebral hemorrhage remains the most severe form of stroke with limited options to improve survival. As the early resuscitation phase in the intensive care unit represents the greatest opportunity for impact on clinical outcome, it also appears to be the most promising window of opportunity to demonstrate a benefit when investigating aggressive treatments.

Conclusion

More research of novel therapies to improve outcomes after intracerebral hemorrhage is desperately needed. The results of the targeted temperature management after intracerebral hemorrhage clinical trial may provide additional information on the applicability of targeted temperature management after intracerebral hemorrhage.

Keywords

clinical trial feasibility human hypothermia safety stroke

Get full access to this article

View all access options for this article.

References

Roger

Lloyd-Jones

. Heart disease and stroke statistics – 2011 update: A report from the American Heart Association. Circulation 2011; 123: e18–209.

Rincon

Mayer

. The epidemiology of intracerebral hemorrhage in the United States from 1979 to 2008. Neurocrit Care 2013; 19: 95–102.

Broderick

Brott

Tomsick

Miller

Huster

. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993; 78: 188–91.

Broderick

Brott

Tomsick

Huster

Miller

. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med 1992; 326: 733–6.

Brott

Broderick

Kothari

. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1–5.

Gebel

Jr Jauch

Brott

. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002; 33: 2636–41.

Mayer

. Hematoma enlargement in intracerebral hemorrhage. J Neurosurg 1994; 81: 333–4.

Mayer

. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 2003; 34: 224–9.

Steiner

Bosel

. Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke 2010; 41: 402–9.

10.

Castillo

Davalos

Alvarez-Sabin

. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 2002; 58: 624–9.

11.

Megyeri

Abraham

Temesvari

Kovacs

Vas

Speer

. Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 1992; 148: 137–40.

12.

Gordon

Merchant

Marmarou

Rice

Marsh

Young

. Effect of murine recombinant interleukin-1 on brain oedema in the rat. Acta Neurochir Suppl (Wien) 1990; 51: 268–70.

13.

Dziedzic

Bartus

Klimkowicz

Motyl

Slowik

Szczudlik

. Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke 2002; 33: 2334–5.

14.

Qureshi

Ali

Suri

. Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: An in vivo microdialysis study. Crit Care Med 2003; 31: 1482–9.

15.

Hua

Keep

Younger

Hoff

. Brain edema after intracerebral hemorrhage: The effects of systemic complement depletion. Acta Neurochir Suppl 2002; 81: 253–6.

16.

Zhao

Steinberg

Sapolsky

. General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb Blood Flow Metab 2007; 27: 1879–94.

17.

Mayer

Sacco

Shi

Mohr

. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology 1994; 44: 1379–84.

18.

Rincon

Lyden

Mayer

. Relationship between temperature, hematoma growth, and functional outcome after intracerebral hemorrhage. Neurocrit Care 2013; 18: 45–53.

19.

Schwarz

Hafner

Aschoff

Schwab

. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000; 54: 354–61.

20.

Nunnally

Jaeschke

Bellingan

. Targeted temperature management in critical care: A report and recommendations from five professional societies. Crit Care Med 2011; 39: 1113–25.

21.

Title 45 Part 46. Protection of Human Subjects. Code of Federal Regulations. 2009.

22.

Moher

Hopewell

Schulz

. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c869.

23.

Jefferson Neuroscience Network. Available at http://www.jeffersonhospital.org/departments-and-services/∼/∼/link?_id=C853243F709F42BE84FAD152D2370B69&_z=z (accessed September 2013).

24.

Rincon

Schorr

Hunter

. Significance of admission temperature and impact on mortality in critically-ill neurological patients. Neurocrit Care 2011; 15(Suppl. 1): 170.

25.

Morgenstern

Hemphill

3rd Anderson

. Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41: 2108–29.

26.

Lyden

Brott

Tilley

. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994; 25: 2220–6.

27.

Hemphill

3rd Bonovich

Besmertis

Manley

Johnston

. The ICH score: A simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32: 891–7.

28.

Badjatia

Strongilis

Gordon

. Metabolic impact of shivering during therapeutic temperature modulation: The Bedside Shivering Assessment Scale. Stroke 2008; 39: 3242–7.

29.

Murkin

Farrar

Tweed

McKenzie

Guiraudon

. Cerebral autoregulation and flow/metabolism coupling during cardiopulmonary bypass: The influence of PaCO2. Anesth Analg 1987; 66: 825–32.

30.

Kollmar

Staykov

Dorfler

Schellinger

Schwab

Bardutzky

. Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke 2010; 41: 1684–9.

31.

Arima

Wang

Huang

. Significance of perihematomal edema in acute intracerebral hemorrhage: The INTERACT trial. Neurology 2009; 73: 1963–8.

32.

Bone

Balk

Cerra

. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009; 136(5 Suppl.): e28.

33.

Teasdale

Jennett

. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2: 81–4.

34.

Van Swieten

Koudstaal

Visser

Schouten

Van Gijn

. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–7.

35.

Fujii

Takeuchi

Sasaki

Minakawa

Tanaka

. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998; 29: 1160–6.

36.

Takahashi

Urano

Nagai

Takada

. Progressive expansion of hypertensive intracerebral hemorrhage by coagulopathy. Am J Hematol 1998; 59: 110–4.

37.

Johansson

Jansson

Stegmayr

Nilsson

Hallmans

Boman

. Hemostatic factors as risk markers for intracerebral hemorrhage: A prospective incident case-referent study. Stroke 2004; 35: 826–30.

38.

Marti-Fabregas

Borrell

Silva

. Hemostatic proteins and their association with hematoma growth in patients with acute intracerebral hemorrhage. Stroke 2010; 41: 2976–8.

39.

Mayer

Brun

Broderick

. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005; 36: 74–9.

40.

Delgado

Alvarez-Sabin

Abilleira

. Plasma d-dimer predicts poor outcome after acute intracerebral hemorrhage. Neurology 2006; 67: 94–8.

41.

Mayer

Brun

Begtrup

. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358: 2127–37.

42.

Broderick

Brott

Duldner

Tomsick

Huster

. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987–93.

43.

Ferreira

Bota

Bross

Melot

Vincent

. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286: 1754–8.

44.

Todd

Hindman

Clarke

Torner

. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005; 352: 135–45.

45.

Kollmar

Juettler

Huttner

. Cooling in intracerebral hemorrhage (CINCH) trial: Protocol of a randomized German-Austrian clinical trial. Int J Stroke 2012; 7: 168–72.

46.

Polderman

Herold

. Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods. Crit Care Med 2009; 37: 1101–20.

47.

Badjatia

Bodock

Guanci

Rordorf

. Rapid infusion of cold saline (4 degrees C) as adjunctive treatment of fever in patients with brain injury. Neurology 2006; 66: 1739–41.

48.

Bernard

Rosalion

. Therapeutic hypothermia induced during cardiopulmonary resuscitation using large-volume, ice-cold intravenous fluid. Resuscitation 2008; 76: 311–3.

49.

MacLellan

Girgis

Colbourne

. Delayed onset of prolonged hypothermia improves outcome after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab 2004; 24: 432–40.

50.

The HACA Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346: 549–56.

51.

Bernard

Gray

Buist

. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346: 557–63.

52.

Clifton

Miller

Choi

. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001; 344: 556–63.

53.

Schwab

Georgiadis

Berrouschot

Schellinger

Graffagnino

Mayer

. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001; 32: 2033–5.

54.

Flint

Hemphill

Bonovich

. Therapeutic hypothermia after cardiac arrest: Performance characteristics and safety of surface cooling with or without endovascular cooling. Neurocrit Care 2007; 7: 109–18.

55.

Gillies

Pratt

Whiteley

Borg

Beale

Tibby

. Therapeutic hypothermia after cardiac arrest: A retrospective comparison of surface and endovascular cooling techniques. Resuscitation 2010; 81: 1117–22.

56.

Caulfield

Finley A

Rachabattula

Eyngorn

. A comparison of cooling techniques to treat cardiac arrest patients with hypothermia. Stroke Res Treat 2011; 2011: 690506.

57.

Fingas

Penner

Silasi

Colbourne

. Treatment of intracerebral hemorrhage in rats with 12 h, 3 days and 6 days of selective brain hypothermia. Exp Neurol 2009; 219: 156–62.

58.

Rincon

Lyden

Mayer

. Early and Late Predictors of Hyperthermia after Spontaneous ICH: On behalf of VISTA Collaborators. International Stroke Conference; 2012.

59.

Greer

Funk

Reaven

Ouzounelli

Uman

. Impact of fever on outcome in patients with stroke and neurologic injury: A comprehensive meta-analysis. Stroke 2008; 39: 3029–35.

60.

Target Temperature Management After Cardiac Arrest (TTM). Available at http://clinicaltrials.gov/ct2/show/NCT01020916?term=hypothermia+cardiac+arrest&rank=49 (accessed September 2013).